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and Giuseppe CarrieriAbstract
Background: Bladder metastases from lung adenocarcinoma are extremely rare; in the seven previously reported
cases, the finding of an intact epithelium overlying the bladder tumour was considered suggestive of a secondary
lesion. We describe the first case of bladder metastasis from lung adenocarcinoma whereby endoscopic appearance
was strongly consistent with primary bladder cancer, thus complicating the differential diagnosis with primary
bladder adenocarcinoma.
Case report: A 65-year-old woman with a 13-year history of clean intermittent catheterization was diagnosed with
a right lung adenocarcinoma metastatic to mediastinal and right supraclavicular nodes, as well as to the left lung,
and treated with six cycles of cisplatin/pemetrexed, followed by six cycles of pemetrexed only. The 18-month
follow-up computed tomography revealed several solid lesions of the bladder wall and she was scheduled for
transurethral resection of bladder tumours. Endoscopic appearance was strongly consistent with primary bladder
cancer but a thorough pathologic evaluation allowed the diagnosis of bladder metastasis from lung adenocarcinoma.
Conclusions: Differentiating primary bladder adenocarcinoma from metastatic adenocarcinoma lesions can be difficult.
An endoscopic appearance consistent with primary bladder cancer further complicates the differential diagnosis, which
heavily relies on pathologic evaluation and specific immunohistochemical staining.
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Lung cancer is the leading cause of cancer-related death
worldwide and adenocarcinoma is the most common
cell type, representing approximately 50% of all lung
cancer cases [1]. Bladder metastases from lung cancer
are uncommon; those originating from lung adenocar-
cinoma are extremely rare. Reviewing the literature, we
found only seven documented cases of bladder metasta-
sis from lung adenocarcinoma, all pointing out difficul-
ties in differentiating secondary adenocarcinoma lesions
from primary bladder adenocarcinoma [2-6]. ln all previ-
ously reported cases, the finding of an intact epithelium
overlying the bladder tumour was considered suggestive* Correspondence: luigicormio@libero.it
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reproduction in any medium, provided the orof a secondary lesion, thus contributing to the differential
diagnosis [3]. Herein, we describe the first case of bladder
metastasis from lung adenocarcinoma in which the endo-
scopic appearance was strongly consistent with primary
bladder cancer, and discuss the diagnostic and therapeutic
challenges of such uncommon clinical condition.Case presentation
A 65-year-old Caucasian woman with a 20 cigarette/day
smoking history was diagnosed in November 2011 with a
right lung adenocarcinoma metastatic to mediastinal and
right supraclavicular nodes as well as to the left lung, stage
T2N3M1b. She was given six cycles of chemotherapy with
cisplatin and pemetrexed, and then maintenance chemo-
therapy with six cycles of pemetrexed only. Follow-up
computed tomography (CT) scans, performed every six
months, showed stable disease until February 2013, whenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Abdominal computed tomography. Several solid lesions protruding into the bladder lumen are seen.
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were revealed (Figure 1). The patient had never had gross
hematuria although she had been on clean intermittent
catheterization since 2000 because of a car accident result-
ing in a severely hypotonic bladder. She was scheduled for
transurethral resection of the bladder tumours; their endo-
scopic appearance was strongly consistent with primary
bladder cancer. Pathology showed tumour cells arranged
in alveolar and papillary pattern deeply infiltrating the
bladder wall (Figure 2). Immunohistochemical staining
was positive for thyroid transcription factor 1 (TTF-1)Figure 2 Lung adenocarcinoma metastatic to the bladder. Tumour cel
papillary pattern (hematoxylin & eosin, original magnification x200).(Figure 3), cytokeratin 7 (CK7) and mucin 1 cell surface
associated (MUC1), while negative for cytokeratin 20
(CK20), and CD15, thus suggesting bladder metastasis
from lung adenocarcinoma.Conclusions
Secondary cancers to the bladder are rare. The majority of
them result from direct extension of tumours from sur-
rounding organs, such as prostate, colorectal, and cervical
carcinomas; the minority are metastasis originating fromls with high nuclear atypia are arranged in alveolar (not shown) and
Figure 3 Tumour cells show nuclear staining for TTF-1 (original magnification x200).
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mours such as breast, lung and skin primaries.
Differentiating secondary adenocarcinoma lesions from a
primary bladder adenocarcinoma can be difficult. In pa-
tients without another known primary adenocarcinoma,
the possibility of bladder cancer being due to spread of a
contiguous-site malignancy should first be sought, but im-
aging studies of the chest, abdomen, pelvis and bones are
also warranted not only for staging but also to rule out the
presence of another possible primary malignancy elsewhere.
Conversely, in patients known to harbour a distant site pri-
mary adenocarcinoma, the differential diagnosis between
primary and metastatic bladder adenocarcinoma relies on
endoscopic appearance [3] and pathologic evaluation.
In the few previously reported cases, the finding of an
intact epithelium overlying the bladder tumour was con-
sidered suggestive of a secondary lesion [3]. Our case is
the first jn which the endoscopic appearance was strongly
consistent with primary bladder cancer. Such a finding,
together with the 13-year history of self clean intermit-
tent catheterization, further complicated the differential
diagnosis between metastatic lung adenocarcinoma and
primary bladder adenocarcinoma. The differential diag-
nosis, therefore, had to rely only on a thorough patho-
logic evaluation.
In the reported case, we elected to use to the TTF-1,
CK7, CK20 immunohistochemical panel, which has re-
cently been described as an effective means of differenti-
ating lung adenocarcinoma from its metastases [6]. The
use of a limited immunohistochemical panel including
napsin A, a recently described highly sensitive marker
for lung adenocarcinoma, and GATA3 and S100P, two
novel markers of urothelial differentiation, has also beenreported to be very useful in differentiating lung adeno-
carcinoma metastatic to the bladder from primary blad-
der adenocarcinoma [4]. In our experience, however, the
TTF-1-CK7-CK20 panel proved to be easier to apply in
routine clinical practice.
In conclusion, the differential diagnosis between sec-
ondary bladder cancers and non-transitional cell primary
bladder cancers has major clinical relevance as primary
bladder cancer is often curable with cystectomy and/or
chemotherapy while bladder metastases from other pri-
maries are managed with palliative chemotherapy and
have a much worse outcome [7,8]. An endoscopic ap-
pearance consistent with primary bladder cancer, as in
the reported case, may further complicate the diagnosis
that should, consequently, be based on the patient’s his-
tory and, above all, on accurate pathologic evaluation
and specific immunohistochemical staining.
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